Key partnership increases access to organoid models

Patient-derived organoids address the urgent need for more predictive in vitro models for biopharmaceutical applications. However, challenges around standardization and scale up remain. Dr. Francisco Morales-Rodriguez shares insight into the partnership between HUB Organoids and Molecular Devices, which aims to increase the access of organoids for both academia and industry. Here, he highlights the integral role of the ImageXpress^® Micro Confocal High-Content Imaging System and its suite of software solutions in providing high image quality, high throughput, and flexibility that HUB Organoids requires.

This video was filmed at SLAS Europe 2024.